2000
DOI: 10.1111/j.1528-1157.2000.tb02945.x
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Safety Monitoring: What to Look for and When to Look for It

Abstract: Summary: This review focuses on the safety problems associated with antiepileptic drugs (AEDs) as rcvealed by laboratory testing and clinical examination. There are two classes of side effccts: (a) common and mild and (b) rare and severe. Allergic reactions to AEDs are common and usually mild. However, on rare occasions, they can progress to more severe cutaneous disorders, including Stevens-Johnson syndrome and toxic epidermal necrolysis. Severe allergic reactions to AEDs range from immune responses with feve… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
28
2
4

Year Published

2002
2002
2015
2015

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 57 publications
(35 citation statements)
references
References 82 publications
(8 reference statements)
1
28
2
4
Order By: Relevance
“…Therefore, the ethics of disclosure and consent can be argued to suggest an obligation for the clinician to share these data when counseling patients regarding AED treatment 68. As an analogy, there is little controversy regarding the advisability of counseling for other rare yet potentially serious AED complications such as Stevens–Johnson syndrome and lamotrigine,69 hepatotoxicity and valproate,70 and aplastic anemia, hepatoxicity, and felbamate 71. Thus, we advocate a balanced discussion with patients regarding the FDA report recommendations, as well as the benefits of seizure control and improved quality of life that AEDs can bring.…”
Section: Counseling Epilepsy Patients About the Fda Aed Suicidality Wmentioning
confidence: 99%
“…Therefore, the ethics of disclosure and consent can be argued to suggest an obligation for the clinician to share these data when counseling patients regarding AED treatment 68. As an analogy, there is little controversy regarding the advisability of counseling for other rare yet potentially serious AED complications such as Stevens–Johnson syndrome and lamotrigine,69 hepatotoxicity and valproate,70 and aplastic anemia, hepatoxicity, and felbamate 71. Thus, we advocate a balanced discussion with patients regarding the FDA report recommendations, as well as the benefits of seizure control and improved quality of life that AEDs can bring.…”
Section: Counseling Epilepsy Patients About the Fda Aed Suicidality Wmentioning
confidence: 99%
“…Thus, we would like to encourage the discussion of modifying the recommendations concerning monitoring at the beginning of a VPA therapy, since it might be an option to detect hepatotoxicity at an early, subclinical stage. Therefore, we suggest considering a short interval of, e. g., one week, during at least the fi rst 3 months of therapy and an intensive clinical vigilance, since the rare occurrence of hepatotoxicity is usually manifest within the fi rst 90 days of treatment [6] . Moreover, the combined use of VPA and duloxetine should be observed with care.…”
Section: Discussion ▼mentioning
confidence: 99%
“…In summary, it is crucial not to misinterpret and = or disregard gastrointestinal symptoms with or without lethargy in patients taking valproic acid, because these could represent the ¢rst clinical signs of pancreatitis and = or hepatic failure, which may become irreversible [19,28,29]. For forensic pathologists valproic acid-induced pancreatitis can be a challenging diagnosis which must not be mistaken for abdominal trauma.…”
Section: Discussionmentioning
confidence: 99%